GlassScriptPhysician profile
Jimmy Lam
NPI 1205326451
$5,816.55
in general payments reported to CMS, 2019-2025
20 companies · $1,495 in 2025
The $1,495 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,726 · 2022: $745 · 2023: $462 · 2024: $1,389 · 2025: $1,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,345.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,798.82 | 2020-2025 | |
| Abbvie INC. | $973.81 | 2022-2025 | |
| Ucb, INC. | $503.62 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $485.34 | 2023-2025 | |
| Amgen INC. | $446.64 | 2022-2025 | Otezla, Otezla |
| Incyte Corporation | $341.28 | 2022-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $253.44 | 2025 | |
| Lilly USA, LLC | $187.65 | 2024-2025 | Taltz, Ebglyss, Zepbound |
| Regeneron Healthcare Solutions, INC. | $136.37 | 2023-2024 | Dupixent |
| Argenx US, INC. | $125.00 | 2023 | Vyvgart |
| E.R. Squibb & Sons, L.L.C. | $122.47 | 2023-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $98.64 | 2024-2025 | |
| Galderma Laboratories, L.P. | $91.57 | 2024-2025 | Nemluvio |
| Leo Pharma INC. | $89.46 | 2025 | Anzupgo, Adbry |
| Janssen Biotech, INC. | $46.62 | 2023-2025 | Tremfya |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pierre Fabre Pharmaceuticals, INC. | $39.16 | 2024 | Hemangeol |
| Krystal Biotech INC | $24.52 | 2023 | Vyjuvek |
| Surgenex LLC | $21.31 | 2025 | Surgraft, Ardeograft, Surmatrix |
| Tactile Systems Technology INC | $17.68 | 2023 | Flexitouch Plus, Entre Plus |
| Dermavant Sciences, INC. | $13.15 | 2023 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.